Vivos Therapeutics, Inc. recently filed a Form 4 with the Securities and Exchange Commission (SEC), indicating significant insider activity within the company. Form 4 is a document required to be filed with the SEC whenever there is a material change in the holdings of company insiders. This could include the buying or selling of company stock by executives, directors, or beneficial owners.
Vivos Therapeutics, Inc. is a company focused on providing innovative solutions for various health issues, particularly in the field of sleep disorders and breathing problems. Their products aim to improve the quality of life for individuals suffering from conditions such as sleep apnea. The filing of Form 4 suggests that there may have been recent transactions by key individuals within the company, signaling potential changes in ownership or investment strategies.
For more information on Vivos Therapeutics, Inc. and their range of products and services, you can visit their official website here. Stay tuned for further developments as the company continues to make strides in the healthcare industry.
Read More:
Vivos Therapeutics, Inc. SEC Filing: Key Details Revealed by Issuer 0001716166
Leave a Reply